CITIGROUP INC - LOXO ONCOLOGY INC ownership

LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 67 filers reported holding LOXO ONCOLOGY INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of LOXO ONCOLOGY INC
ValueSharesWeighting
Q4 2018$7,664,000
+614.3%
54,719
+770.5%
0.01%
+700.0%
Q3 2018$1,073,000
-39.6%
6,286
-38.6%
0.00%
-50.0%
Q2 2018$1,776,000
+1941.4%
10,239
+1258.0%
0.00%
Q1 2018$87,000
+50.0%
754
+9.0%
0.00%
Q4 2017$58,000
-70.7%
692
-67.7%
0.00%
Q3 2017$198,000
-70.4%
2,145
-74.3%
0.00%
-100.0%
Q2 2017$670,000
+33.7%
8,349
-29.8%
0.00%
Q1 2017$501,000
+47.8%
11,892
+12.7%
0.00%
Q4 2016$339,000
+1030.0%
10,548
+805.4%
0.00%
Q3 2016$30,000
-9.1%
1,165
-17.6%
0.00%
Q2 2016$33,000
-84.2%
1,413
-81.5%
0.00%
Q1 2016$209,000
+154.9%
7,640
+165.7%
0.00%
Q4 2015$82,0002,875
+287400.0%
0.00%
Q3 2015$0
-100.0%
1
-99.5%
0.00%
Q2 2015$4,000
+33.3%
210
+6.6%
0.00%
Q1 2015$3,000
-57.1%
197
-68.2%
0.00%
Q4 2014$7,000
+250.0%
620
+388.2%
0.00%
Q3 2014$2,0001270.00%
Other shareholders
LOXO ONCOLOGY INC shareholders Q1 2016
NameSharesValueWeighting ↓
Aisling Capital LLC 4,028,920$129,409,00030.09%
Casdin Capital, LLC 360,000$11,561,0009.55%
DAFNA Capital Management LLC 139,722$4,487,0003.94%
Opaleye Management Inc. 125,000$4,014,0002.36%
Eventide Asset Management 740,000$23,765,0001.55%
Crawford Lake Capital Management, LLC 52,713$1,693,0001.22%
AWM Investment Company, Inc. 180,000$5,781,0001.13%
Orbimed Advisors 1,728,000$55,495,0000.71%
DRIEHAUS CAPITAL MANAGEMENT LLC 423,276$13,594,0000.48%
EAM Investors, LLC 111,268$3,573,0000.48%
View complete list of LOXO ONCOLOGY INC shareholders